More Press Releases

View Older Stories View Newer Stories

Apr 8, 2024 04:52PM ROSEN, A LEADING LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
Apr 8, 2024 04:51PM Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Checkpoint Therapeutics, Inc. (CKPT) Investors
Apr 8, 2024 04:50PM CO2 GRO Inc. Announces the Commissioning of Its Largest Global Commercial Project with Hidroexpo
Apr 8, 2024 04:49PM Chicago Atlantic Closes $20 Million Facility with Nova Farms
Apr 8, 2024 04:48PM ROSEN, A TOP RANKED LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTYX
Apr 8, 2024 04:48PM Norfolk Southern to participate in fireside chat with Wolfe Research
Apr 8, 2024 04:48PM Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
Apr 8, 2024 04:45PM Cantargia presents unique effects of nadunolimab in pancreatic cancer
Apr 8, 2024 04:46PM Margex Expands Trading Options with Addition of Four New USDT Pairs
Apr 8, 2024 04:45PM Phanes Therapeutics' PT217 granted Fast Track Designation by the FDA
Apr 8, 2024 04:44PM Cohen & Steers Announces Preliminary Assets Under Management and Net Flows For March 2024
Apr 8, 2024 04:45PM Nano Labs Files Annual Report on Form 20-F for Fiscal Year 2023
Apr 8, 2024 04:41PM NOTICE TO DISREGARD -- LeaseQuery
Apr 8, 2024 04:40PM Qalby Etmaan in Gaza
Apr 8, 2024 04:41PM Believe It or Not! Total Solar Eclipse Captured for Ripley’s Exhibit Collection
Apr 8, 2024 04:40PM Verita announces claims leadership team
Apr 8, 2024 04:39PM Southwest Gas Announces Launch of Centuri Initial Public Offering Roadshow
Apr 8, 2024 04:35PM Certain DWS Closed-End Funds Declare Monthly Distributions
Apr 8, 2024 04:35PM Onco360 Has Been Selected as the Sole National Specialty Pharmacy Partner for Voydeya® (danicopan)
Apr 8, 2024 04:34PM Cathie Biga is New American College of Cardiology President
Apr 8, 2024 04:33PM Cabot Corporation to Announce Second Quarter 2024 Operating Results
Apr 8, 2024 04:30PM Spetz Enhances Cash Flow with Debt Conversion Plan
Apr 8, 2024 04:30PM Trumpeter/Composer Etienne Charles Debuts as a Big Band Leader with "Creole Orchestra," Arriving June 14 on Culture Shock Records
Apr 8, 2024 04:30PM Mandalay Resources Corporation Announces Strong Production Results and Growing Cash Balance for First Quarter 2024
Apr 8, 2024 04:30PM Stratasys Elevates Customer Service and Operations, Welcoming a New COO
Apr 8, 2024 04:30PM Enviva Receives NYSE Notice Regarding Delayed Form 10-K Filing
Apr 8, 2024 04:30PM Harmonic Announces CEO Succession
Apr 8, 2024 04:30PM ASUR Announces Total Passenger Traffic for March 2024
Apr 8, 2024 04:30PM Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 
Apr 8, 2024 04:30PM Exai Bio to Present New Breast Cancer Data at the American Association for Cancer Research (AACR) 2024 Annual Meeting
Apr 8, 2024 04:30PM ProAssurance Announces Dates for Release of First Quarter 2024 Results Release and Investor Teleconference
Apr 8, 2024 04:30PM Tubulis Presents Preclinical Data for Solid Tumor Targeting ADC Candidates TUB-030 and TUB-040 Demonstrating Superior Efficacy Profile and a Wide Therapeutic Window at the AACR Annual Meeting 2024
Apr 8, 2024 04:30PM The Real Brokerage to Host First Quarter 2024 Earnings Conference Call
Apr 8, 2024 04:30PM Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
Apr 8, 2024 04:30PM Skillz Receives NYSE Notice Regarding Late Form 10-K Filing
Apr 8, 2024 04:30PM PanTher Therapeutics Presents Positive First-in-Human Data for PTM-101 in Pancreatic Cancer at AACR Annual Meeting
Apr 8, 2024 04:30PM Expanded Rochester Mine Achieves Commercial Production; Ramp-Up on Schedule
Apr 8, 2024 04:30PM Nuvalent Presents New Preclinical Data Supporting Profiles of HER2-Selective Inhibitor, NVL-330, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2024
Apr 8, 2024 04:30PM WARNER BROS. DISCOVERY TO REPORT FIRST-QUARTER 2024 RESULTS ON THURSDAY, MAY 9
Apr 8, 2024 04:30PM Masonite Announces Date of First Quarter 2024 Earnings Release
Apr 8, 2024 04:30PM Invitation Homes Agrees to Acquire Approximately 500 Additional Newly Built Homes
Apr 8, 2024 04:30PM Vicarious Surgical to Report First Quarter 2024 Financial Results on April 29, 2024
Apr 8, 2024 04:30PM Team, Inc. Appoints Pamela J. McGinnis to Its Board of Directors
Apr 8, 2024 04:30PM Angi Appoints Jeff Kip as CEO
Apr 8, 2024 04:25PM 420 with CNW — Pew Poll Finds Only 11% of Americans Want to Retain Ban on Marijuana
Apr 8, 2024 04:30PM Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform
Apr 8, 2024 04:30PM Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference
Apr 8, 2024 04:30PM Chart Industries Announces Amended Revolving Credit Facility
Apr 8, 2024 04:30PM Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting
Apr 8, 2024 04:30PM Interpublic Schedules First Quarter 2024 Earnings Release
View Newer Stories View Older Stories